The medication exerts its therapeutic effects through multiple mechanisms
As a result, CJC-1295 DAC offers sustained levels of growth hormone in the body, which can potentially lead to increased muscle growth, improved recovery, and enhanced fat metabolism (1)
Research shows higher rates of diabetes remission, better cardiovascular health, and improved quality of life in surgical patients compared to those relying solely on medication
Semaglutide acts like GLP-1, which assists in boosting insulin release, stopping glucagon secretion and delaying stomach emptying
These results are unprecedented for any pharmaceutical intervention targeting metabolic dysfunction-associated steatotic liver disease (MASLD, formerly called NAFLD)